COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants | Scientific Reports - Nature.com

5/3/2022 12:00:00 AM3 years 9 months ago

Scientific Reports - COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants

Sample collection for assay validation 16 serum samples consisting of 12 samples from COVID-19 patients (ethical approval #179/2020/BO2, University Hospital Tübingen) and four negative pre-pandemic … [+13424 chars]

full article...